Disability InsurersEmployersLawyersMVA Insurers

Are Statins Really Any Good?

August 1, 2024 from The Conservative Woman

Statins are some of the most commonly prescribed medications, lauded for their ability to prevent fatal heart attacks and strokes by lowering cholesterol. In the UK, the NHS spends £100 million annually, issuing over 70 million prescriptions for statins. However, despite their widespread use, statins have been at the center of a heated debate, with some experts calling them a “great cholesterol scam,” while others emphasize their life-saving potential.

So, who should patients trust: the pharmaceutical industry that promotes statins through clinical trials or doctors who warn of their potential side effects?

 

A Pharmaceutical Goldmine

The global statin market was valued at $15 billion in 2021, with projections to rise to $35 billion by 2030. Statins, like Lipitor (originally manufactured by Pfizer and now distributed by Viatris), come with a long list of side effects. According to the medication’s public information leaflet (PIL), common side effects include increased blood sugar levels, joint and muscle pain, and abnormal liver function—risks that are particularly concerning for diabetic and pre-diabetic patients.

Uncommon side effects include insomnia, blurred vision, and skin rashes, while rare effects range from tendon injuries to hepatitis and visual disturbances. Alarmingly, “very rare” side effects, which include anaphylaxis and hearing loss, were once considered to affect only 1 in 1,000,000 patients but now occur in 1 in 10,000.

Perhaps most concerning is the experience of Dr. Duane Graveline, a former NASA physician who developed global amnesia after taking statins. His case, among others, raises serious concerns about the neurological impacts of these medications. Graveline discovered that 4.4 patients per 1,000 experienced cognitive impairments during Pfizer’s clinical trials, but global amnesia was not listed as a potential side effect.

The Debate Over Cholesterol

Statins are prescribed to lower cholesterol, but some experts question whether cholesterol is the true villain in heart disease. According to Dr. Malcolm Kendrick, author of The Great Cholesterol Con, cholesterol is not the cause of heart attacks. Instead, he argues that cholesterol helps repair damaged blood vessels, and the traditional belief that it forms harmful plaques may be misguided.

Dr. Zoë Harcombe, a public health expert, reviewed data from the World Health Organization (WHO) and found that higher cholesterol is linked to lower mortality rates in both men and women. She points out that the diet-heart hypothesis, which blames cholesterol for heart disease, has not been consistently supported by global data.

The documentary Statin Nation adds another layer to the debate, noting that while British men have the 15th lowest cholesterol levels in Europe, the UK has one of the highest rates of heart attacks. This suggests that lowering cholesterol on a population level might not have the intended impact on reducing heart disease.

 

The Nocebo Effect: Are Statin Side Effects Psychosomatic?

While many patients report side effects from statins, some experts argue that these symptoms may not be directly caused by the drug. Professor Peter Sever of Imperial College London conducted a large study showing that 20% of patients in both the placebo and statin groups reported side effects like muscle pain and stomach problems. He concluded that many of these symptoms might be due to the nocebo effect—where negative expectations lead to perceived harm.

However, critics, such as cardiologist Dr. Aseem Malhotra, argue that up to 20% of patients suffer from genuine side effects, far exceeding the 1% figure quoted by some industry experts. He suggests that tackling obesity would have a far greater impact on reducing heart disease than prescribing statins.

 

Statins and Life Expectancy

A study highlighted by Dr. Kendrick in 2015 showed that taking a statin for five years would increase life expectancy by an average of just 3.5 days, or about 0.75 days per year of treatment. For many patients, the potential for side effects may not justify such a modest benefit in lifespan.

Professor Colin Baigent, a cardiovascular epidemiologist from Oxford University, offers a different perspective, suggesting that if all over-75s took statins, up to 8,000 deaths a year could be prevented. But even he admits that statins are not a “universal panacea,” and their use must be balanced against the risk of side effects.

=================================================================

 

Considering an IME or document review to resolve an insurance claim, legal file, or workplace health and safety issue?

Our specialists provide evidence-based opinions, so get in touch with Western Medical today to learn more about our services.